| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,526 | 15,455 | 15,864 | 21,684 | | Cost of Revenue | 8,490 | 7,868 | 9,884 | 17,118 | | | Gross Profit | 5,036 | 7,587 | 5,981 | 4,565 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,671 | 2,670 | 2,501 | 1,726 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
| 309 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,365 | 4,917 | 3,479 | 2,531 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 362 | 198 | 204 | 358 | | Earnings Before Interest And Taxes | 1,145 | 4,526 | 3,074 | 2,207 | | Interest Expense | 417 | 444 | 426 | 431 | | Income Before Tax | 728 | 4,082 | 2,648 | 1,776 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (382) |
-
|
-
| (109) | | | | Net Income From Continuing Ops | (2,435) | 4,082 | 2,648 | 1,776 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 346 | 4,082 | 2,648 | 1,776 | | Preferred Stock And Other Adjustments | 312 | (215) | (98) |
-
| | | Net Income Applicable To Common Shares | $658 | $3,868 | $2,550 | $1,776 |
|
0.03% Nasdaq 
0.55 (3.81%) 
Income Statement
